Literature DB >> 10392752

Merosin-positive congenital muscular dystrophy in two siblings with cataract and slight mental retardation.

U C Reed1, A M Tsanaclis, M Vainzof, S K Marie, M S Carvalho, J Roizenblatt, C C Pedreira, A Diament, J A Levy.   

Abstract

We report on two siblings that have been followed for 14 years, with merosin-positive congenital muscular dystrophy (CMD), cataract, retinitis pigmentosa, dysversion of the optic disc, but no cerebral anomalies, except for microcephaly and slight mental retardation (MR). The younger child had three generalized seizures easily controlled by anticonvulsant therapy. Both children presented hypotonia from birth, delayed psychomotor development, generalized muscular weakness, and atrophy and joint contractures of knees and ankles. The course of the disease, apparently static during the first 10 years of life, became progressive during the second decade with loss of deambulation by the age of 13. Creatine kinase was increased in both children. Bilateral cataract was diagnosed at 6-months of age. In spite of the occurrence of microcephaly, MR was slight and the siblings acquired reading and writing skills after the aged 10. Head magnetic resonance imaging showed normal results in both siblings. The classification of these cases within the broad spectrum of CMD is difficult since most of the known muscle-eye-brain syndromes generally show severe MR and brain anomalies. We consider these cases as corresponding to the rarer syndromes of merosin-positive CMD with associated features such as cataract and MR that were particularly emphasized during the 50th ENMC International Workshop on CMD [Dubowitz V. Workshop report: 50th ENMC International workshop on congenital muscular dystrophy. Neuromusc Disord 1997;7:539-547]. Further genetic, pathological, neuroradiological, and immunocytochemical studies will be necessary for better elucidation of the classification and pathogenesis of CMD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392752     DOI: 10.1016/s0387-7604(98)00100-4

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

1.  Mutations in INPP5K, Encoding a Phosphoinositide 5-Phosphatase, Cause Congenital Muscular Dystrophy with Cataracts and Mild Cognitive Impairment.

Authors:  Manuela Wiessner; Andreas Roos; Christopher J Munn; Ranjith Viswanathan; Tamieka Whyte; Dan Cox; Benedikt Schoser; Caroline Sewry; Helen Roper; Rahul Phadke; Chiara Marini Bettolo; Rita Barresi; Richard Charlton; Carsten G Bönnemann; Osório Abath Neto; Umbertina C Reed; Edmar Zanoteli; Cristiane Araújo Martins Moreno; Birgit Ertl-Wagner; Rolf Stucka; Christian De Goede; Tamiris Borges da Silva; Denisa Hathazi; Margherita Dell'Aica; René P Zahedi; Simone Thiele; Juliane Müller; Helen Kingston; Susanna Müller; Elizabeth Curtis; Maggie C Walter; Tim M Strom; Volker Straub; Kate Bushby; Francesco Muntoni; Laura E Swan; Hanns Lochmüller; Jan Senderek
Journal:  Am J Hum Genet       Date:  2017-02-09       Impact factor: 11.025

2.  Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy.

Authors:  Daniel P S Osborn; Heather L Pond; Neda Mazaheri; Jeremy Dejardin; Christopher J Munn; Khaloob Mushref; Edmund S Cauley; Isabella Moroni; Maria Barbara Pasanisi; Elizabeth A Sellars; R Sean Hill; Jennifer N Partlow; Rebecca K Willaert; Jaipreet Bharj; Reza Azizi Malamiri; Hamid Galehdari; Gholamreza Shariati; Reza Maroofian; Marina Mora; Laura E Swan; Thomas Voit; Francesco J Conti; Yalda Jamshidi; M Chiara Manzini
Journal:  Am J Hum Genet       Date:  2017-02-09       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.